BACKGROUND: Although numerous studies have demonstrated obesity as an aspect of the insulin resistance syndrome in cardiovascular disease (CVD), the mechanism is not clear. Central adiposity, acting through many CVD risk factors, including, plasma glucose, insulin, total cholesterol, low density lipoprotein-cholesterol (LDL-C) and lipoprotein moities-apolipoprotein B (ApoB), apolipoprotein A-I (ApoAI), by atherogenic and thrombotic mechanisms has been proposed as a possible mechanism. In this study, we examined the relationship between central fat distribution (de®ned by waist circumference) and the ratio of these lipoproteins (ApoBaApoAI). SUBJECTS AND METHODS: Association between ApoBaApoAI ratio and waist circumference was compared in Blacks (n 854) and Whites (n 2552) using the NHANES III population-based samples. Correlation analyses and multiple regression analyses were used to determine the association between ApoBaApoAI and waist circumference, controlling for age, body mass index (BMI), race, gender, plasma glucose, insulin, serum triglyceride and total cholesterol. RESULTS: Adjusting for age, ApoBaApoAI was signi®cantly correlated with waist circumference (Black men: r 0.38, White men: r 0.26, Black women: r 0.20, White women: r 0.36) (all P`0.01). Adjusting for age and triglyceride or insulin, waist circumference was also positively correlated with CVD risk factors including, ApoB, LDL-C, plasma glucose and fasting insulin, and inversely correlated with ApoAI and HDL-C in Blacks and Whites (P`0.05). Overall, triglyceride and total cholesterol were the strongest predictors of ApoBaApoAI in Blacks and Whites adjusting for age, BMI and insulin, than waist girth (P`0.01). CONCLUSIONS: The result of this study suggests the need to investigate ApoBaApoAI as another possible facet in the insulin resistant syndrome.
Introduction
Although numerous epidemiological studies have demonstrated that obesity is one facet of the insulin resistance syndrome in cardiovascular disease (CVD), the mechanism is not clear. It has been speculated that through abnormal fat distribution (central adiposity), obesity is a major factor in the pathological progression concluding in CVD. 1 ± 3 The association between adiposity and CVD is traditionally assessed by anthropometric parameters such as the body mass index (BMI) and waist-to-hip ratio (WHR). BMI is a height-independent measure of weight, often used as a measure of body size and the degree of fatness, the use of which is contentious due to its correlation with fatness being not consistent across populations. 4 Although WHR measures central fat deposition, it is an imperfect measure of visceral fat mass, particularly in lean individuals. 5 Some studies have shown that waist circumference may be a better predictor of CVD than BMI and WHR. 6 ± 8 Waist circumference is a surrogate of total body and abdominal fat accumulation, not accounted for by either BMI or WHR. 8 Waist circumference is a better correlate of the visceral adipose tissue than BMI or WHR. 8 Visceral adipose tissue is associated with the constellation of factors comprising the insulin resistance syndrome, which includes hyperinsulinaemia, glucose intolerance, hypertension, hyperglyceridaemia and high levels of low-density lipoprotein (LDL-C). 9 Some have postulated that the action of central adiposity on CVD is through lipoprotein moitiesapolipoprotein B (ApoB) and apolipoprotein A-I (ApoAI) by atherogenic and thrombotic mechanisms. 10 ± 14 ApoAI is the activator of lecithin (cholesterol acyltransferase) which esteri®es plasma cholesterol that mobilizes residual cholesterol from cells. 15, 16 ApoB aids in the delivery of cholesterol to peripheral tissue. 13, 15, 16 Several studies have demonstrated that ApoB, ApoAI and triglyceride (TG) are independent risk factors for CVD. 10,15 ± 19 Hence, these lipoproteins and TGs (triglycerols) are seen as another possible aspect of the syndrome linking obesity with CVD. Although an elevated ratio of ApoB and ApoAI (ApoBaApoAI) has been found to be a powerful index for discriminating between survivors of myocardial infarction and controls, as well as an independent risk factor for CVD, 20, 21 it has received only limited consideration, particularly in terms of its relationship with central fat distribution. Traditionally, many studies investigating the association between lipoproteins and CVD are often restricted to their parent cholesterol (LDL-C and high-density lipoprotein, HDL-C), although more and more studies are now looking at TGs, apolipoproteins and their molecular variants as potential risk factors for CVD.
The objectives of this investigation were twofold: Firstly, examine and compare the relationship between ApoBaApoAI and central fat distribution (de®ned by waist circumference) in a biracial US population sample, and secondly, to determine if the relationships between ApoBaApoAI and waist circumference were affected by other variables including age, BMI, plasma glucose, insulin, serum TG and total cholesterol.
Methods
Data from the third US National Health and Nutrition Examination Survey (NHANES III) were used in this investigation. NHANES III was a multistage probability sample of the noninstitutionalized civilian US population groups, examined in two phases between 1988 ± 1994. The sampling and measurement procedures have been described in detail elsewhere. 19,22 ± 24 Only subjects aged 17 ± 90 y, who participated in glucose analysis after an overnight fast, were eligible for this investigation. Pregnant women and those on insulin or hypoglycaemic agents were excluded from analyses. This study was also restricted to individuals for whom anthropometric variables, including age, weight, height, waist and hip were obtained, and also to those who were assayed for total cholesterol, fasting insulin, serum ApoB, serum ApoAI and serum TG. Waist measurement was made at the natural waist or at the midpoint between the bottom of the rib cage and the top of the iliac crest, for each subject at minimal respiration to the nearest 0.1 cm. Detailed methods used in measuring cholesterol, TG, HDL-C and LDL-C cholesterol have been described elsewhere. 19, 24 Brie¯y, ApoB and ApoAI were measured by radial immunodiffusion in the ®rst 8.2% of the specimens and by rate immunonephelometry for the remaining. 19 Based on the above criteria, a total of 3406 persons (854 Blacks and 2552 Whites) were eligible for this investigation.
Statistical methods
Statistical programs available in SPSS for Windows were utilized for these analyses. 25 Means and standard deviations for ApoBaApoAI and descriptive variables were computed and compared across race and gender.
We used empirical waist cut-points ( ! 94.00 cm for men and ! 80.00 cm for women) based on the study by Lean et al, 26 to compare mean values of ApoBaApoAI across race and gender. Our justi®ca-tion to use these cut points was due to the high degree of agreement between the above waist circumference values and BMI (BMI ! 25 kgam 2 ) with speci®city and sensitivity of 97.5% and 96%, respectively. With the above cut points, Lean et al 26 also found that waist circumference identi®ed subjects with high WHR ( ! 0.95 for men and ! 0.80 for women) with 97.5% and 96% speci®city and sensitivity, respectively. The above BMI cut points are consistent with the World Health Organization (WHO) recommendation, and the WHR is within the range suggested by the US Department of Agriculture (USDA) for Americans. WHO speci®es a normal BMI as within 20 ± 25 kgam 2 and the USDA recommends a WHR of 0.95 for men and 0.80 for women, for determining risk of CVDs. 27, 28 To obtain normality, TG values were log 10 transformed, prior to analyses. Gender and race speci®c Pearson's correlation analysis was used to assess the correlation between waist circumference and other variables. Partial correlation analyses were also performed to determine the association between ApoBaApoAI and traditional CVD risk factors including, plasma glucose, insulin, TG and total cholesterol, controlled for age and BMI. Gender and race speci®c multiple regression analysis with ApoBaApoAI as the dependent variable and waist girth as the independent variable, was used to determine the association between ApoBaApoAI and waist circumference adjusted for age, BMI, plasma glucose, insulin, TG and total cholesterol. The customary P-values of 0.05 were used to specify statistical signi®cance. Table 1 describes the anthropometric and clinical characteristics of the study participants. Although Blacks were younger, they were signi®cantly heavier as determined by weight and BMI (P`0.05). Overall, the total cholesterol values for Blacks and Whites were slightly elevated, but within clinically acceptable values. Glucose, TG, HDL-C and LDL-C concentrations were also within clinically desirable values for both Whites and Blacks. The values of ApoBaApoAI were signi®cantly higher among Whites compared to Blacks and were greater among men than women. The largest relative difference between men and women in mean ApoBaApoAI was in White with a value of 0.10.
Results
Mean values of ApoBaApoAI strati®ed by race, gender and age, are presented in Figure 1 . Overall, White men and White women had signi®cantly higher levels of ApoBaApoAI than Black men and Black Central adiposity and ApoB to ApoAI ratio IS Okosun et al women, respectively, at each age group (P`0.05). The pattern of ApoBaApoAI variation with age in men and women, was the same in Black and White, tending to increase with age with the highest values occurring in White males in the 50 ± 59 y age group. The lowest mean values of ApoBaApoAI were among Black males and Black females aged`20 y, with values of 0.60 each.
To describe gender and race speci®c trends in waist and ApoBaApoAI values, we calculated mean values of ApoBaApoAI, based on waist empirical cut-points (Table 2) . Among each waist quartile, White men had larger waist sizes than Black men, while Black women (except ®rst quartile) had larger waist sizes than White women (P`0.01). There was a consistent trend of increasing means of ApoBaApoAI with increasing waist size for both men and women (test for trends, P`0.001).
We also compared means of ApoBaApoAI across empirical waist cut-points, recommended by Lean et al. 26 Subjects with`abnormal' waist circumference ( ! 94 cm for men and ! 80 cm for women) had statistically higher values (0.87 and 0.74, for men and women, respectively) of ApoBaApoAI compared to normal (0.72 and 0.61 for men and women, Table 3 presents age-adjusted Pearson's correlation coef®cients between waist circumference and ApoBaApoAI, ApoAI, ApoB, TG, HDL-C, LDL-C, glucose, insulin and total cholesterol by gender and race. In the univariate correlation analysis, waist circumference was positively correlated with ApoBaApoAI, ApoB, TG, LDL, glucose, insulin and total cholesterol in Black and White men and women (P`0.05). Also, waist circumference was inversely correlated with ApoAI and serum HDL-C cholesterol in Blacks and Whites (P`0.01).
Due to the strong degrees of correlation for TG and insulin, with waist circumference in the univariate analyses, we adjusted for each, to determine their independent effect on the association between waist girth and ApoBaApoAI. When adjusted for TG, waist circumference was positively correlated with ApoBaApoAI, ApoB, LDL-C (except in Black women), plasma glucose and insulin in Blacks and Whites (P`0.01). Comparing the univariate models with TG-adjusted models, there were decreases in the values of ApoBaApoAI regression coef®cients by 23%, 42%, 43% and 35% for Black men, White men, Black women and White women, respectively. Further analyses were carried out, which adjusted for fasting insulin. Again, waist girth was independently related with ApoBaApoAI in Black men, White men, Black women and White women (P`0.05). Compared with TG adjusted analyses, serum LDL-C (in Black men and Black women), plasma glucose (in Black men) and ApoAI (in Black women) were no longer signi®cant, while total cholesterol (in White men and White women) and ApoB (in Black women), became signi®cant in insulin adjusted analyses (P`0.05). The degree of correlation between waist circumference and insulin was higher than between waist circumference and other variables in the TG and non-TG adjusted models (P`0.01).
We performed gender and race-speci®c multiple regression analyses using ApoBaApoAI as the dependent variable and waist circumference as the independent variable adjusting for age, BMI, plasma glucose, insulin, TG and total cholesterol (Table 4 ). In both Black men and White women, waist circumference was independently and signi®cantly associated with increasing ApoBaApoAI controlling for age, BMI, plasma glucose, insulin, TG and total cholesterol (P`0.05). Also, ApoBaApoAI was associated with Table 3 Correlation of Waist Circumference with apolipoprotein Baapolipoprotein A-I (ApoBaApoAI) Ratio and Other Lipid variables Table  4 . ApoBaApoAI was correlated with waist circumference in Black men (r 0.15; P`0.01). In all groups, ApoBaApoAI was also correlated with traditional CVD risk factors of total cholesterol (Black men: r 0.46, P`0.01, White men: r 0.46, P`0.01, Black women: r 0.57, P`0.01, White women: r 0.46, P`0.01), glucose (Black men: r 0.13, P`0.05), TG (White men: r 0.20, P`0.01, Black women: r 0.14, P`0.01, White women: r 0.15, P`0.01), and insulin (White women: r 0.08, P`0.05).
To avoid bias, we repeated all analyses, excluding those with medical conditions that might in¯uence lipids, such as diabetes mellitus, coronary heart disease (CHD) and hypertension, as well as cigarette smoking and alcohol use. Similar results of the independent correlation between ApoBaApoAI and waist circumference were observed (data not shown).
Discussion
Although obesity is one known factor in insulin resistance syndrome, 29 ± 31 its independent role in CVD is not well understood. To investigate the role of obesity, several investigators have de®ned different forms of adiposity and their separate relationship to CVD. Traditionally, BMI and WHR are the most commonly used indices in the literature. Recent investigations show, however, that waist circumference as an absolute and aggregate measure of total fat distribution, is a better risk factor for CVDs than WHR or BMI. In fact, an analysis by Chan et al 32 shows that one can achieve a better discrimination of CVD risks using waist girth, rather than using WHR or BMI
The present investigation uses population-based to provide information about the relationship between central fat distribution, de®ned by waist circumference and the ratio of two important apolipoproteins that are known to be independent risk factors for CVD. The mean values of ApoB for Black and White men and women, were less than the cut points suggested (ApoB ! 120 mgadl) to be associated with increased risk of CVD. 33 When we used this cut point in our analyses, the prevalence rates of ApoB ! 120 mgadl were 23%, 33%, 20% and 30% for Black men, White men, Black women, and White women, respectively. Based on the suggested 34 value of`120 mgadl, the prevalence rates of ApoAI were 13%, 23%, 9% and 11% for Black men, White men, Black women and White women, respectively. These individuals may be regarded as having abnormal ApoB and ApoAI and at risk for CVD. 33, 34 Although abdominal adiposity has been hypothesized to increase TG and TG is widely regarded as an important factor in the enhanced and reduced production of small LDL-C and HDL-C, respectively, 35 ± 37 there are few studies that have adjusted for TG. Except the three studies 11, 38, 39 investigating ApoB and ApoAI, to our knowledge there are no investigations using ApoBaApoAI, that adjusted for TG. Due to the strong degrees of correlation of TG and insulin with ApoBaApoAI in univariate analyses and because hypertriglyceridaemia is frequently accompanied by a state of insulin resistance, 40 we adjusted for TG and insulin, to account for their possible confounding effect.
Although our data are cross-sectional and causality cannot be established, we have shown that ApoBaApoAI is positively correlated with abdominal fat distribution in a biracial population sample, independent of age. We have also shown that the correlation persists, even after adjusting for TG or insulin. In agreement with previous ®ndings, 38,41 ± 43 our study showed that increasing waist circumference was associated with increased ApoB, TG, serum LDL-C, plasma glucose, insulin and total cholesterol concentrations, and decreased concentrations of ApoAI and serum HDL-C. We have also shown that TG and total cholesterol were independently associated with ApoBaApoAI, and were stronger predictors of ApoBaApoAI in all four groups than waist girth, BMI, glucose and insulin. For reasons yet to be de®ned, the correlation between waist girth and ApoBaApoAI was weaker and the association lacking among White men and Black women compared to Black men and White women.
Conclusion
Additional studies are needed to de®ne lifestyle changes appropriate for reduction ApoBaApoAI levels in these populations. The result of this study suggests the need to investigate ApoBaApoAI as another possible facet in the complexity of the socalled insulin resistance syndrome.
